Association of timing of initiation of pharmacologic venous thromboembolism prophylaxis with outcomes in trauma patients. Issue 1 (January 2021)

• Record Type: Journal Article
• Authors: Hecht, Jason P.; Han, Emily J.; Cain-Nielsen, Anne H.; Scott, John W.; Hemmila, Mark R.; Wahl, Wendy L.
• Is Part Of: Journal of trauma and acute care surgery. Volume 90:Issue 1(2021)
• Publication Date: 2021-01
• Subjects: Venous thromboembolism -- venous thrombosis -- pulmonary embolism -- heparin -- low-molecular-weight heparin; Surgical intensive care -- Periodicals; Surgical emergencies -- Periodicals; Wounds and injuries -- Surgery -- Periodicals; 617.026
• DOI: 10.1097/TA.0000000000002912
• Languages: English
• ISSNs: 2163-0755

Abstract

Abstract : BACKGROUND: Patients are at a high risk for developing venous thromboembolism (VTE) following traumatic injury. We examined the relationship between timing of initiation of pharmacologic prophylaxis with VTE complications. METHODS: Trauma quality collaborative data from 34 American College of Surgeons Committee on Trauma–verified levels I and II trauma centers were analyzed. Patients were excluded if they were on anticoagulant therapy at the time of injury, had hospitalization <48 hours, or received no or nonstandard pharmacologic VTE prophylaxis (heparin drip). Patient comparison groups were based on timing of initiation of VTE prophylaxis relative to hospital presentation (0 to <24 hours, 24 to <48 hours, ≥48 hours). Risk-adjusted rates of VTE events were calculated accounting for patient factors including type of pharmacologic agent in addition to standard trauma patient confounders. A sensitivity analysis was performed excluding patients who received blood in the first 4 hours and/or patients with a significant traumatic brain injury. RESULTS: Within the 79, 386 patients analyzed, there were 1, 495 (1.9%) who experienced a VTE complication and 1, 437 (1.8%) who died. After adjusting for type of prophylaxis and patient factors, the risk of a VTE event was significantly increased in the 24- to <48-hour (odds ratio, 1.26; 95% confidence interval, 1.09–1.47; p = 0.002) and ≥48-hour (odds ratio, 2.35; 95% confidence interval, 2.04–2.70; p < 0.001) cohorts relative to patients initiated at 0 to <24 hours. These VTE event findings remained significant after exclusion of perceived higher-risk patients in a sensitivity analysis. CONCLUSION: Early initiation of pharmacologic VTE prophylaxis in stable trauma patients is associated with lower rates of VTE. LEVEL OF EVIDENCE: Diagnostic, level III. Abstract : Supplemental digital content is available in the text.